Officials warn that invasive snails can harm your health as well as Georgia wildlife
They say these species can harbor a type of worm that can potentially cause illness in humans if eaten.
In a recent cooperative study, the department partnered with Dr. Tyler Achatz's parasitology lab at Middle Georgia College, and examined two species of invasive aquatic snails, the apple and mystery snail, for various parasites.
The snails were collected from multiple locations around the state and tested for the presence of various parasites.
[DOWNLOAD: Free WSB-TV News app for alerts as news breaks]
The tests confirmed a low-level presence of rat lungworm in both species.
The parasite can be transmitted to people when snails or slugs are eaten raw or undercooked.
Though an infection of rat lungworm is very low, in extremely rare cases, infection can lead to eosinophilic meningitis, with complications including the possibility of death.
The Atlanta-based Centers for Disease Control says the parasite does not replicate in humans and cannot transmit between humans.
For more information on invasive species, including apple and mystery snails, and how to report sightings, visit GeorgiaWildlife.com/ans.
TRENDING STORIES:
US Postal Service says it has suspended inbound packages from China, Hong Kong
Atlanta-based designer featured in Target campaign feels 'gaslit' after DEI changes
Former DA breaks down as she testifies in illegal interference trial over handling of Arbery case
[SIGN UP: WSB-TV Daily Headlines Newsletter]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Child at daycare eats kratom, needs to be revived, police say
A former preschool employee in Mableton has been charged with child cruelty after a 2-year-old was found unresponsive and revived with Narcan. [DOWNLOAD: Free WSB-TV News app for alerts as news breaks] An arrest warrant has been issued for a former preschool employee who is charged with cruelty to children. According to the warrant, Kennesha Floy is accusing of leaving 7tabz on a shelf that a 2-year-old ingested. Police said the child was unresponsive before Narcan was administered by paramedics. The incident allegedly happened on Aug. 8. Investigators said Floyd admitted to leaving the tablets on a shelf at Bright Minds Learning and Childcare Center. According to the warrant, 7tabz contains 7-Hydroxymitragynine, with compounds from Kratom. Police said the tablets were left in a room with multiple children. Officials did not provide an update on the child's condition. Channel 2 Cobb County Bureau Chief Michele Newell stopped by the preschool and received a statement from the school, saying the health and safety of the children is of the utmost importance. 'A wrapper from a purchased energy tablet fell on the floor in a classroom and a child picked it up,' they said. 'The teacher in the class retrieved it right away, but the child had put a piece of the wrapper in their mouth. It has been determined that the product caused a severe reaction for the child.' The daycare's spokesperson said they are cooperating with law enforcement officials during the investigation. 'The product that appears to have caused the reaction was not purchased by the school and the school was not aware of the product being in the school,' they said. 'We have reviewed and updated our policies to prevent any similar incidents in the future. The staff member is no longer employed at Bright Minds.' A man who works across the street from the preschool said he was shocked to see police outside of the building. 'I saw a lot of law enforcement cars here on that day. They stayed here all day. I thought that was very unusual. This is one of the best daycares here in the city of Mableton for many years. This daycare has always supported the community a lot of kids go there,' Anthony Guillory said. The Georgia Department of Early Care and Learning told Channel 2 it is currently investigating allegations concerning the health and safety environment at the daycare. In a statement regarding the alleged incident DECAL said: 'The Department is looking closely into reports of indoor storage hazards, as well as concerns regarding a lack of adequate supervision and vigilant oversight at the facility. DECAL's foremost priority is the safety and well-being of Georgia's children. The Department will conduct a thorough review of the center's practices, policies, and physical environment to determine the circumstances surrounding this incident and to ensure all licensing requirements are being met. Pending the investigation, DECAL is working closely with all relevant parties to address the situation promptly and transparently. The Department will implement corrective actions as needed to ensure the safety and security of all children in care at Bright Minds Learning and Childcare Center. No further information will be provided at this time, as the investigation is ongoing. DECAL remains committed to upholding the highest standards of child care in the State of Georgia and will provide updates as appropriate upon the conclusion of the investigative process. The incident was self-reported by Bright Minds Learning and Childcare Center,' said DECAL Chief Communications Officer Reg Griffin. [SIGN UP: WSB-TV Daily Headlines Newsletter] Solve the daily Crossword
Yahoo
3 hours ago
- Yahoo
This Cannabis Stock Just Transformed Into a Bitcoin Treasury Play. Should You Buy Shares Now?
It seems that companies whose products and services are not finding takers in the current market are pivoting at the drop of a hat to become Bitcoin (BTCUSD) treasury companies. While the most prominent among them has been the Michael Saylor-led MicroStrategy (MSTR), recently, two biotech companies have also 'rebranded' their business operations to load up on the world's largest cryptocurrency. Among the latest companies to join this bandwagon is cannabis company KindlyMD (NAKA). Valued at a market cap of $90 million, KindlyMD's shares have surged an impressive 742% in the year to date. More News from Barchart Trade the Warren Buffett Rally in UnitedHealth Stock With This High-Reward, Low-Risk Options Strategy Apple Expects $1.1 Billion Tariff Hit in 4th Quarter After $800 Million Q3 Hit; CEO Tim Cook Warns 'Many Factors That Could Change' Cathie Wood Is Buying BLSH Stock After the Bullish IPO. Should You? Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. About KindlyMD Founded in 2019, KindlyMD is a Utah-based healthcare provider that specializes in alternative pain management, including through medicinal cannabis use. Its licensed clinicians integrate cannabis therapy into holistic care plans, positioning the company as one of the largest Qualified Medical Providers (QMPs) within Utah's regulated medical cannabis framework. But this is all set to go up in smoke as the company has been acquired by Bitcoin-centric investment firm Nakamoto Holdings. After the merger, the combined company will operate with the KindlyMD name and with the ticker symbol NAKA. The whole transaction generated $540 million in gross proceeds through a private placement in public equity (PIPE) financing, with a $200 million convertible note also closed. Thus, with a $740 million war chest, the company aspires to acquire 1 million BTC. Commenting on the deal, CEO David Bailey said, 'Our vision is for the world's capital markets to operate on a Bitcoin standard. Today's merger represents the beginning of that journey for our company.' Bailey will continue to remain the CEO of the merged entity. Co-founder of KindlyMD and ex-CEO Tim Pickett was also upbeat about the deal, saying, 'We are thrilled to officially close our merger with Nakamoto. We've built KindlyMD on operational and innovative excellence, and we are now extending that same principle to our capital strategy. Bitcoin gives us the ability to preserve value with the same integrity we apply to delivering care.' So, that begs the question: Is NAKA stock a viable investment option now? KindlyMD Posts Widening Losses, Declining Revenues KindlyMD reported revenues of $408,527 in Q2 2025, down 36.1% from the previous year, while net losses widened dramatically to $2.4 million from $1.3 million in the year-ago period. Operational losses also increased, coming in at $2.4 million compared to just over $1 million in the same period a year ago. Net cash outflow from operating activities widened to $2.8 million from $1.1 million in the year-ago period as the company closed the quarter with a cash balance of $6.02 million. This was higher than its total debt levels of $432,978. The Bottom Line After the merger, KindlyMD and NAKA stock look like little more than a passing fad. Just a company that is hoping to take advantage of the Bitcoin treasury momentum as a trade, with no solid operational plans. Thus, avoiding NAKA shares would be a wise choice on the part of investors. On the date of publication, Pathikrit Bose did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
Do Wall Street Analysts Like Solventum Stock?
With a market cap of $12.4 billion, Solventum Corporation (SOLV) is an independent healthcare company that develops, manufactures, and markets innovative solutions to meet critical patient and customer needs worldwide. Its business spans four segments: Medsurg; Dental Solutions; Health Information Systems; and Purification and Filtration, serving healthcare providers through direct sales, distribution, and digital platforms. Shares of the Maplewood, Minnesota-based company have outperformed the broader market over the past 52 weeks. SOLV stock has increased 21.4% over this time frame, while the broader S&P 500 Index ($SPX) has gained 16.4%. However, shares of the company have risen 8.1% on a YTD basis, lagging behind SPX's 9.7% return. More News from Barchart Lyft Generates Huge FCF Margins - LYFT Stock Is Too Cheap Trade the Warren Buffett Rally in UnitedHealth Stock With This High-Reward, Low-Risk Options Strategy Powell, Trump Talks and Other Can't Miss Items this Week Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Looking closer, Solventum stock has also outpaced the Health Care Select Sector SPDR Fund's (XLV) 10.8% decrease over the past 52 weeks. Shares of Solventum rose 2% on Aug. 7 after the company reported Q2 2025 adjusted EPS of $1.69 and revenue of $2.2 billion, above Wall Street forecasts. Growth was driven largely by its MedSurg segment, where sales rose 4.8% to $1.2 billion, reflecting robust demand for wound care and surgical sterilization products, alongside lower expenses. Additionally, management raised its full-year adjusted EPS guidance to $5.80 - $5.95, as easing U.S.-China tariff risks reduced expected headwinds. For the fiscal year ending in December 2025, analysts expect SOLV's adjusted EPS to decline 11.9% year-over-year to $5.90. The company's earnings surprise history is mixed. It topped the consensus estimates in three of the last four quarters while missing on another occasion. Among the 13 analysts covering the stock, the consensus rating is a 'Moderate Buy.' That's based on four 'Strong Buy' ratings, eight 'Holds,' and one 'Strong Sell.' This configuration is more bullish than three months ago, with one 'Strong Buy' rating on the stock. On Aug. 8, Piper Sandler increased its price target on Solventum to $94 while maintaining an 'Overweight' rating. As of writing, the stock is trading below the mean price target of $87.12. The Street-high price target of $103 implies a modest potential upside of 44.2% from the current price levels. On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
